COVID-19 is a contagious respiratory illness caused by the coronavirus. It spreads quickly from person to person
through respiratory droplets when an infected person coughs, sneezes, or talks.
COVID-19 Prevention Clinical Trials
In pursuit of advancing preventive measures against COVID-19 and other viral respiratory illnesses, Koch Research undertook a comprehensive clinical trial. This pivotal investigation was meticulously designed to evaluate both the efficacy and safety of an investigational medication aimed at mitigating the risk of contracting these contagious diseases. Specifically targeting healthcare workers and individuals deemed at high risk of exposure to the coronavirus, our trial sought to assess the potential of this innovative medication in preventing viral respiratory infections within these vulnerable populations.
Current Status
Not Recruiting
Total Studies
02
Enrollment Process
Clinical trials are essential for advancing medical knowledge and improving patient care by testing the efficacy and safety of potential treatments before they are widely available to the public. Here’s what you can expect when considering enrollment.
Recruitment
Recruiting volunteers is the first step of an active clinical trial.
Phone Screening
You will undergo a phone screening to determine your eligibility.
Informed Consent
You must sign an ICF defining the purpose, procedure, potential risks & benefits, and your rights as participants.
